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translation of mouse model 
to human gives insights into 
periodontitis etiology
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per Hoffmann  11,12, Matthias Laudes13, Wolfgang Lieb14, Andre franke  15, 
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To suggest candidate genes involved in periodontitis, we combined gene expression data of periodontal 
biopsies from Collaborative Cross (CC) mouse lines, with previous reported quantitative trait loci (QTL) 
in mouse and with human genome-wide association studies (GWAS) associated with periodontitis. 
Periodontal samples from two susceptible, two resistant and two lines that showed bone formation 
after periodontal infection were collected during infection and naïve status. Differential expressed 
genes (DEGs) were analyzed in a case-control and case-only design. After infection, eleven protein-
coding genes were significantly stronger expressed in resistant CC lines compared to susceptible 
ones. Of these, the most upregulated genes were MMP20 (p = 0.001), RSPO4 (p = 0.032), CALB1 
(p = 1.06×10−4), and AMTN (p = 0.05). In addition, human orthologous of candidate genes were tested 
for their association in a case-controls samples of aggressive (Agp) and chronic (cp) periodontitis 
(5,095 cases, 9,908 controls). In this analysis, variants at two loci, TTLL11/PTGS1 (rs9695213, 
p = 5.77×10−5) and RNASE2 (rs2771342, P = 2.84×10−5) suggested association with both AgP and CP. 
In the association analysis with AgP only, the most significant associations were located at the HLA 
loci HLA-DQH1 (rs9271850, P = 2.52×10−14) and HLA-DPA1 (rs17214512, P = 5.14×10−5). This study 
demonstrates the utility of the cc RiL populations as a suitable model to investigate the mechanism of 
periodontal disease.
Periodontitis (PD) is one of the most common complex inflammatory diseases in human. The disease is believed 
to be a multifactorial trait which initiated by compositional shift of the oral micro biome because of different 
stimuli resulting in destruction of tissues surrounding the teeth. The precise mechanisms underlying individual 
disease susceptibility or that drive the individual steps in the pathogenesis of PD have largely remained unknown. 
Previous genome-wide association studies (GWAS) of chronic periodontitis (CP) reported several ‘suggestive’ 
susceptibility loci but failed to produce genome-wide significant evidence of association1–6. GWAS that used the 
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rare but severe and early-onset form aggressive periodontitis (AgP), which is believed to have a stronger genetic 
component, or studies that combined AgP and CP analysis samples to increase the statistical power, identified 
five genome-wide significant loci7–9. Compared to other complex diseases, the low number of statistically signif-
icant genetic risk loci likely reflects the relatively small sample sizes of the available PD cohorts. Given these size 
limitations and the general scarcity of high-quality phenotype-genotype cohorts for PD, GWAS alone are unlikely 
to identify the missing susceptibility loci. Here, the mouse model provides an appropriate and powerful system 
to identify genes that have a role in the etiology of complex human diseases. Given that expression patterns in 
mouse models recapitulate those in humans10, the examination of differences in gene expression as a response 
to different environmental exposures in genetically identical mice and between genetically different mice living 
in the same environmental context, can give direct insight into the mechanism that lead to disease susceptibility. 
Additionally, the genes underlying these differences can be mapped as quantitative trait loci (QTL)11. These QTLs 
and the differently expressed genes (DEGs) can be translated to the human orthologous genes and serve as can-
didates for genetic association studies in human case-control samples. Recently, we demonstrated the strength 
of combining genome-wide expression profiling and QTL-mapping in a F2 mouse population and identified the 
human chromosomal region at PF4/PPBP/CXCL5 to carry genetic susceptibility variants of AgP and CP12. In the 
current study, we used recombinant inbred mouse lines of the Collaborative Cross (CC) that were descended 
from eight divergent strains of mice: A/J, C57BL/6 J, 129S1/SvImJ, NOD/LtJ, NZO/HiLtJ, CAST/Ei, PWK/PhJ, 
and WSB/EiJ and specifically designed for high-resolution mapping of QTLs13. Briefly, this population provide 
an increased level of genetic and phenotypic diversity compared to other existing mouse genetic reference pop-
ulations14. The full description of the CC population under development in our labs at Tel-Aviv University and 
its power for dissecting complex traitsis described in recent publications13,15–20. In previous studies, we identified 
CC-RILs with increased susceptibility and resistance to PD as a result of mixed infection with the oral bacteria 
Porphyromonas gingivalis (P.g) and Fusobacterium nucleatum (F.n)21 and mapped two QTLs that were associated 
with alveolar bone loss in the CC mouse population22. In the current study, we hypothesized that in response to 
an identical challenge of bacterial infection, resistant and susceptible CC-RILs have different gene expression 
profiles. The identification of the significant DEGs could pinpoint putative molecular pathways and mechanisms 
that contribute to disease resistance and susceptibility. These genes also provide reasonable candidate genes for 
association studies in human case-control analyses populations of PD. To test our hypothesis, we investigated 
the expression patterns of oral tissues in six susceptible and resistant CC-RILs before and after mixed infection 
with P.g. and F.n.21. We identified a set of genes to be significantly upregulated in resistant CC-RILs after bacterial 
infection. We present new data that support the previously suggested susceptibility genes TTLL11, HLA-DOA 
and LBP, and propose HLA-DQH1 and RNASE2 as novel risk factors for AgP and PD.
Results
Gene enrichment analysis. The Principle Component Analysis (PCA) showed that at 42 days after infec-
tion, the largest variation within the 24 samples was between the genetically different RILs (e.g. resistant vs. 
susceptible vs. bone formation group) rather than between the infection/control conditions (Appendix-Fig. 1). 
All of RNAseq raw data were submitted to GEO website for allowing freely public access. The accession num-
ber of the raw data is GSE145474, and can be access by website: https://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE145474.
Differential gene expression in periodontal tissues in susceptible, resistant, and 
bone-formation RILs after oral bacterial infection compared to mock-infection. For each of 
the three phenotypes, we tested the differential gene expression between infected vs. non-infected individuals 
(Appendix-Table 1). This analysis showed how each of the three groups specifically responded to bacterial infec-
tion on the transcription level, giving a potential mechanistic link between the phenotype and specific DEGs. 
Eleven DEGs were observed in the phenotype “resistant”, and two within the phenotype “susceptible”. No sig-
nificant DEG was observed for the phenotype “bone formation”. All DEGs except of Bpifa6 could be mapped 
to an orthologous autosomal gene in the human genome (Xist is a non-coding RNA gene that is located on the 
X-chromosome. This chromosome was excluded from the human GWAS data set and the subsequent analy-
ses).Obp2b showed homology with the two human genes OBP2A and OBP2B (Appendix-Table 1).
Differential gene expression in periodontal tissues between the susceptible, resistant and 
bone-formation RILs after oral bacterial infection. We next analyzed the differences in gene expres-
sion between the three genetically different phenotype groups after bacterial infection. The gene expression after 
bacterial infection of the CC-RILs of one phenotype group was compared with the gene expression after bacterial 
infection of the CC-RILs of the other two-phenotype groups. 1,326 genes were differentially expressed between 
infected susceptible and resistant RILs, 823 genes were differentially expressed between infected susceptible RILs 
compared to infected RILs of the bone formation, and 1,572 genes were differentially expressed between infected 
resistant RILs compared to the bone formation group (Padj < 0.05, log2FC > 1). Heatmaps of the expressed val-
ues for each comparison are shown in Appendix-Fig. 2. The ten strongest up regulated and the ten strongest 
down-regulated genes of each comparison are shown in Appendix Table 2. The regulated genes in the suscep-
tible group were significantly related to immune response pathways FDR < 0.05 as shown in Appendix-Fig. 3. 
Functional network analyses of DEGs within the observed pathways are shown in Appendix Figs. 4, -5 and -6.
To nominate candidate genes that have a role in the etiology of PD, we selected the ten most up- or down-
regulated DEGs, the DEGs that mapped to the QTLs Perio3 and Perio4 or that were suggested as risk genes by 
published human GWAS on PD. The QTLs Perio3 and Perio4 comprised 81 mouse genes (Appendix Table 3). 
Six DEGs (PARP1, DUSP23, PCDH17, PSEN2, H3f3aos, EPHX1) located to the QTLs Perio3 and Perio4 (Table 1, 
H3f3oas and Dusp23 have no human orthologous and showed only borderline significance with P = 0.07). 15 
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DEGs had been reported in previous human GWAS on periodontitis with P < 9 × 10−6 (C1orf87, HLA-DOA, 
BIRC5, CCDC13, GLDC, GPR141, OTOF, IFI16, ETNK2, TTLL11, ATP5S, GRID1, LBP, NIN, and VAV1; 
Appendix Table 4). A potential gene regulatory network between QTLs associated with susceptibility to alveolar 
bone loss in CC mice with DEGs in susceptible vs. resistant lines and bone formation groups was proposed and 
shown in Appendix Figure 3; two genes within the significant QTL Perio3, Psen2 and Parp1, showed a HUB gene 
pattern.
Candidate gene association study in case-control samples of AgP and CP. We selected the human 
orthologous genes of the 13 DEGs (and 200 kb up- and downstream to include putative regulatory sequences) 
that were identified after comparing the transcriptional response of the CC-RILs to bacterial infection with 
mock-infection. First, the common SNPs of these regions were examined for associations with the disease pheno-
type AgP. The smallest p-value was observed for a region upstream OBP2A (rs1329505, P = 7.85 x E-04), located 
~73 kb upstream of SNP rs1537415 at GLT6D1 that was previously reported to be associated with AgP with 
genome-wide significance8. Next, the variants at these loci were tested for association in a meta-analysis of AgP 
and CP. In this meta-analysis, the strongest association was observed for a large chromosomal region at RPL29 
(chr3:51,874,679–52,220,203; with p = 9.3 ×10E-05; rs16943). This region was previously reported to be asso-
ciated with macrophage inflammatory protein 1b levels at a genome-wide significance level23. According to the 
GWAS Catalog, the tested genetic regions comprise 55 genome-wide significant associations and 61 suggestive 
associations with various phenotypes, as well as 5,903 eQTLs. These variants were tested for association in AgP 
and the meta-analysis of AgP and CP, if genotypes where available for both, the AgP and CP samples.
Next, we tested the associations of the common variants of the human orthologous genes (+ 200 kb up- and 
downstream) that corresponded to the ten most up- or downregulated DEGs, the DEGs that mapped to the QTLs 
Perio3 and Perio4 or that were suggested as risk genes by published human GWAS on PD (Table 1+ Appendix 
Table 2+ Appendix Table 4). In total, 23,413 SNPs were tested for association with AgP (896 cases, 7,104 con-
trols). In this analysis, 6,423 SNPs indicated an association with p < 0.05. The most significant associations were 
located at the HLA loci HLA-DQH1 (rs9271850, P = 2,52−14) and HLA-DPA1 (rs17214512, P = 5,14−05; Fig. 1, 
Table 2). In the AgP-CP meta-analysis that combined the AgP and CP samples (5.095 cases, 9.908 controls), the 
HLA loci lost significance. Instead, a genetic region at TTLL11 (tubulin tyrosine ligase-like family, member 11), 
upstream PTGS1 (prostaglandin G/H synthase 1), (chr9, rs9695213, P = 5.77 ×10−5 [in AgP only the association 
was P = 8.1 ×10−3]) and at RNASE2 (Ribonuclease A Family Member 2) (chr14, rs2771342, P = 2.84 ×10−5 [in 
AgP only the association was not significant]) showed the most significant associations (Fig. 2, Table 2). The 
chromosomal region at TTLL11 was previously suggested to be associated with increased quantities of P.g. col-
onization of the human oral cavity before1. In addition to these loci, among the DEGs that mapped to the QTLs 
Perio3 and Perio4 and had additionally been suggested in previous human GWAS on PD as putative risk loci of 
PD, variants at LBP (chr.20) suggested association in the AgP-CP Meta-analysis (rs1780616, P = 1.67 ×10−3 [AgP; 
rs1780616, P = 7,78 ×10−3]).
Discussion
This is the first study to investigate the transcriptome of periodontal tissues from susceptible, resistant and 
“bone-formation” RILs after infection with the periodontal bacteria P.g and F.n and at a naive status.
The comparison of gene expression with and without bacterial infection in mice of the resistant RILs, the 
susceptible RILs and the bone forming RILs, showed that the difference in gene expression in response to bacte-
rial infection was strongest in the resistant RILs. Here, we identified eleven significant DEGs. Among the most 
upregulated genes were AMTN and CALB1, which are involved in calcium-binding, a relevant process in bone 
formation. Likewise, the genes PAPLN and FBN2 are glycoproteins of the extracellular matrix, which is involved 
in regrowth and healing of tissue. Notably, after bacterial or mock-infection we did not identify significant DEGs 
in the susceptible and bone formation RILs. This may relate to the small sample size, which putatively caused false 
negative findings. Otherwise, the functional context of the significant DEGs we identified in the resistant RILs 
may point to the relevance of processes of tissue regeneration to maintain oral health under bacterial challenge. 
This may indicate that under particular strong bacterial infection as in our experimental setting, the resistance of 
bone loss was caused by a particular capacity in the regeneration of tissue integrity that was certainly harmed by 
the invading pathogens. Correspondingly, in our experimental setting disease susceptibility or resistance did not 
result from special features of the immune response.
Gene 
Name Description Chr. Padj (Comparison)
Psen2 presenilin_2 1 0.037 (O/R)
Dusp23 dual_specificity_phosphatase_23 1 0.07 (O/R)
Ephx1 epoxide_hydrolase_1,_microsomal 1 0.01 (S/O)
H3f3aos H3_histone,_family_3A,_opposite_strand 1 0.07 (S/R)
Pcdh17 protocadherin_17 14 0.09 (S/R); 0.04(O/R)
Parp1 poly_(ADP-ribose)_polymerase_family,_member_1 1 0.05 (O/R); 0.039 (S/O)
Table 1. The table lists six genes and their Padj, which underlie the previous QTL (Perio3 and Perio4) and 
showed significant deferential expression between one or more of three comparisons. (O; bone formation group, 
S; susceptible group, R; resistant group).
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The screening for genes that were differentially expressed between the three RILs after bacterial infection 
identified a very large number of several hundreds to thousands of DEGs. This could relate to the extensive 
genetic variability between these RILs, which may have induced “transcriptional noise” that precluded the iden-
tification of DEGs relating to a different response to bacterial infection. However, the number of DEGs between 
the mock-infected RILs of the different phenotype groups was considerably lower compared to the number of 
genes that differed in expression between the RILs after bacterial infection, indicating that the response to the 
infection caused most of the observed differential expression. The comprehensive set of genes that were differen-
tially regulated after oral bacterial infection can provide a useful reference for human studies, which relate to bac-
terial induced oral diseases like PD. More specifically, we note that the chromosomal region at TTLL11 showed 
the smallest p-value of association in the CP-AgP meta-analysis together with a significant association in the 
AgP-only analysis. The chromosomal region at TTLL11 was previously described to be associated with increased 
quantities of P.g.1. However, the causative variants and their putative target genes are unknown and we note that 
the association also locates upstream to the cyclooxygenase PTGS1. However, the independent rediscovery of this 
locus despite the lack of bacterial data together with the suggestive association with AgP and in the meta-analysis 
of AgP and CP, argues for a true positive association finding. The missing statistical evidence for the suggested 
risk loci may generally relate to the relatively small sample size of the available PD analysis samples, compared to 
other complex common diseases. Given the size limitations of the available PD cohorts, true positive associations 
of genetic variants with moderate effects or with a lower MAF are unlikely to generate p-values, which pass a 
correction threshold necessary for thousands of independent tests. Thus, the sample size was a major limitation 
of the human association study. But similarly, this limitation explicitly argues for a complimentary approach to 
GWAS, in a manner described in the current work.
Figure 1. Regional association plots of the most significant associations with AgP case-control cohort that 
located at the HLA loci, (A) HLA-DQH1 and (B) HLA-DPA1.
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Likewise, we identified a suggestive association with the gene LBP (Lipopolysaccharide binding protein) that 
was earlier reported to be associated with CP4. The soluble acute-phase protein LBP binds to bacterial lipopol-
ysaccharide (LPS) to elicit immune responses. Although the association at this locus was weak in our study, the 
independent rediscovery argues for a true positive finding.
In the association study that excluded CP patients, we observed a strong association with the 
HLA-DOA/-DAP1 locus, which was reported in a GWAS on CP before. However, this association was only sig-
nificant in our AgP case-control sample and not in the AgP-CP meta-analysis. This can indicate a false negative 
finding due to different classification of CP in our study and the previous GWAS. However, a true negative find-
ing cannot ruled out at this stage and this association needs clarification. Likewise the strong association with 
HLA-DQH1 was only observed in our AgP case-control sample but not in the CP sample.
In summary, this study generated valuable information by giving independent support for the genetic regions 
at DAB2IP/TTLL11, HLA-DOA and LBP to be involved in the genetic etiology of PD and propose HLA-DQH1 
and RNASE2 as novel risk factors for AgP and CP. This demonstrates the utility of RILs of the CC as a controlled 
model system of bacteria induced PD for the discovery of susceptibility genes of human PD.
Locus Nearest Gene(s) A1 A2 Stage OR L95 U95 P(Q) I2 Mod P
1 rs2771342
14q11.2
METTL17 
(downstream to 
RNASE2)
C T AgP-Ger 1.12 0.99 1.26 0.08
AgP-NL 0.92 0.73 1.16 0.49
CP-EA-mod 1.15 1.04 1.28 0.00
CP-EA-sev 1.13 0.98 1.30 0.08
Pooled 1.12 1.05 1.19 0.37 0.04 FE 7.41E-04
CP-Ger 1.19 1.05 1.36 0.01
Pooled (all) 1.13 1.07 1.20 0.42 0.00 FE 2.84E-05
2 rs9695213
9p24.1
MRRF (upstream to 
TTLL11, downstream 
PTGS1)
G A AgP-Ger 1.19 1.00 1.42 0.05
AgP-NL 1.38 0.99 1.93 0.06
CP-EA-mod 1.27 1.09 1.48 0.00
CP-EA-sev 1.22 0.99 1.50 0.07
Pooled 1.24 1.13 1.37 0.86 0.00 FE 7.91E-06
CP-Ger 1.01 0.84 1.22 0.88
Pooled (all) 1.19 1.09 1.30 0.34 0.12 FE 5.77E-05
3 rs1780616
20q11.23 AL391095.1 - LBP T C AgP-Ger 1.14 1.01 1.29 0.04
AgP-NL 1.25 0.98 1.58 0.07
CP-EA-mod 1.07 0.97 1.19 0.18
CP-EA-sev 1.17 1.01 1.35 0.04
Pooled 1.13 1.05 1.20 0.62 0.00 FE 5.44E-04
CP-Ger 1.01 0.88 1.15 0.92
Pooled (all) 1.10 1.04 1.17 0.42 0.00 FE 1.67E-03
4 rs9271850
HLA-DQH1
A G AgP-Ger 1.53 1.34 1.74 2.54E-10
AgP-NL 1.66 1.32 2.09 1.75E-05
Meta-AgP 1.56 1.39 1.75 0.54 0.00 FE 2.52E-14
5 rs17214512
HLA-DPA1
A G AgP-Ger 1.31 1.12 1.54 9.53E-04
AgP-NL 1.44 1.07 1.93 1.64E-02
Meta-AgP 1.34 1.16 1.54 FE 5.14E-05
Table 2. Five SNPs showed significant association with one of the tested three cohorts either separately or/
and as a pooled samples. (AgP-Ger; The German AgP samples, AgP-NL; Dutch AgP samples, Mod-CP; 
European American moderate CP cases, Sev-CP; European American severe CP cases, CP-Ger; German CP 
samples, A1 = Effect allele; A2 = Non-effect allele; EAF = Effect allele frequency; Cas = Cases; Con = Controls; 
OR = Odds ratio; CI = Confidence interval; P(Q) = Cochranes Q P-value; I2 = Heterogeneity index; Mod = 
Model; RE = Random effects; FE = Fixed effects; P = P-value).
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Materials and Methods
CC-RIL selection and assessment. Experiments were performed at the Department of Prosthodontics, 
Faculty of Dental Medicine, and Hadassah Medical Center, Israel and at the Department of Clinical Microbiology 
and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel. All mouse experimental protocols used 
in this project approved by the Institutional Animal Care and Use Committee (IACUC) at Tel Aviv University 
in Israel, with numbers M-08-044, which adherers to the Israeli guidelines, which follows the National Institute 
of Health (NIH) of United States of America (USA) animal care and use protocols. Mice were monitored daily 
by the student for their overall health status. Mice, which were observed to suffer (less movement and activity) 
from the infection, and based on the consultation with the Veterinarian at the small animal unit, were terminated. 
Furthermore, based on the approved protocol, mice which lost 10% of their bodyweight between two measured 
points, or 20% overall, of their initial bodyweight, were also terminated. Termination procedure of mice during 
assessment based animal suffering or at endpoint of the experiment was based of injection of Ketamine and 
Xylazine with dose of 100 mg/kg (body weight) and 10 mg/kg (bodyweight), respectively for initial euthanasia, 
and subsequently by CO2 chamber.
Experimental CC-RILs mice at age 8 to 12 wk of the International Livestock (IL) cohort, were provided by the 
Small Animal Facility, Faculty of Medicine, Tel Aviv University, Israel, and were assessed for their alveolar bone 
changes in response to a mixed oral infection with a well-known periodontal pathogen. In the current study we 
used the mixed infection model using the P.g. bacteria as a known key bacteria in periodontitis24,25 mixed with 
F.n. as another known pathogenic bacteria from the orange complex26. As we showed in our previous studies, the 
Figure 2. Regional association plots of the loci DAB2IP/TTLL11 and RNASE2, which suggested association 
in the meta-analyis of AgP and CP with p < 10−04. (A) DAB2IP/TTLL11. Left panel: The association upstream 
TTLL11, tagged by rs3763649, was observed in the discovery meta-analysis using AgP and CP cases and 
controls. Right panel: After exclusion of the CP case-control samples, the associated region was identical to 
the genetic locus associated with increased quantities of P.G. in humans (Red rectangle = region associated 
with increased quantities of P.G. in humans. (B) RNASE2. Left panel: The association of the suggested novel 
susceptibility locus of PD was strongest in the meta-analysis using AgP and CP cases and controls. Right panel: 
After exclusion of the CP case-control samples, the associated region was less significant, possibly reflecting the 
reduced statistical power.
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mixed bacteria mimic the periodontal infection in human and induce a prominent bone loss in mice27. Briefly, 
each CC line was divided in an infected and a control group. The mice were treated with Sulfamethoxazole 
(0.8 mg/ml) in drinking water for a continuous period of ten days, followed by an antibiotic-free period of three 
days, before oral application of mixed culture of P.g. (strain 381) and F.n. (strain PK1594) (control groups were 
treated with PBS and 2% Carboxymethycellulose)27,28. 42 days after the last infection, the mice were sacrificed and 
the alveolar bone volume at the second molar of the left hemi-maxilla was evaluated by micro–computed tomog-
raphy (µCT)29. The CC lines showed significant variation in their response to the mixed infection. While suscep-
tible CC lines showed significant decrease in bone volume (P < 0.05) after infection, the resistant CC lines did not 
show significant change in bone volume after infection. In addition, a group of CC-RILs showed increase in bone 
volume and was named “bone formation group”22. For each of the phenotypes “resistant”, “susceptible” and “bone 
formation”, two strains were selected for differential gene expression analysis (Appendix Figure 8). Because sex 
effect on changes in the alveolar bone volume was not observed, both sexes were treated equally. Tissue samples 
from gingiva, alveolar bone, periodontal ligament and teeth were collected as mixed tissues from two resistant CC 
lines (TAU-IL188, TAU-IL111), two susceptible CC lines (TAU-IL785, TAU-IL551) and two CC lines that showed 
bone formation after 42 days of oral bacterial infection (TAU-IL2124, TAU-IL2126). Of each strain, total RNA of 
two biological replicates were sequenced (RNAseq) after bacterial infection and after mock-infection. In the cur-
rent study, these are designated as cases and controls, respectively. Table 3 summarizes the experimental setting.
RNA isolation, RNA-sequencing and Differential gene expression analysis in CC-RILs. Total high 
molecular weight genomic RNA was purified using the RNeasy kit (Qiagen, Hilden, Germany). RNA quality was 
assessed using a BioAnalyzer (Agilent Technologies, Palo Alto, CA, USA). Samples with the RNA integrity number 
(RIN) ≥ 7 was used to prepare a library of template molecules.The mRNA was sequenced with a single-end technol-
ogy (read length of 75) on NextSeq. 500 platform (Illumina, San Diego, USA). Alignment was performed to mouse 
genome version GRCm38. Quality control assays and differential expression results, were calculated and visualized 
in R (version 3.3.1)30 using R package DEseq. 223. The significance threshold was taken as Padj<0.05. First, we ana-
lyzed the differences in gene expression in response to the different environmental exposure (bacterial infection vs. 
mock-infection) within each phenotype group (susceptible, resistant or bone formation). For each phenotype group, 
two independent CC-RILs with the same phenotype were analyzed. From each of these CC-RILs, two biological 
replicates were included. These two replicates were combined with the other two replicates of the second CC-RIL 
with the same phenotype, to exclude random effects of a single line, resulting in four samples (see Table 3). Second, 
between the CC-RILs that developed different phenotypes under the same environmental exposure, we analyzed the 
differences in gene expression. In a case-only design, the gene expression levels of infected CC-RILs of one pheno-
type group were compared with the gene expression levels of infected CC-RILs of the other two phenotype groups 
(e.g. susceptible vs. resistant and susceptible vs. bone formation).
Biological processes associated with the regulated genes. We tested the general differences between 
each type of response after bacterial infection (resistant, bone formation and susceptible) and considered the 
basal gene expression differences of the tested CC lines. Biological processes at Padj<0.05 associated with the 
generated differentially expressed genes and potential regulatory networks between the generated DEGs and 
the previous periodontitis QTL in CC mice were defined using the IPA software (QIAGEN Inc. https://www.
qiagenbioinformatics.com/products/ingenuity-pathway-analysis). Subsequently, we performed functional net-
work analyses of each gene underlying the most significant pathway.
Selection criteria of candidate DEGs for association mapping in the human case-control 
samples. 
 1. DEGs derived from the comparison infected vs. non-infected for each of the three phenotypes (N = 13).
 2. The ten most up regulated and the ten most down-regulated DEGs of the comparisons of the different 
phenotypes after bacterial infection (resistant vs. susceptible vs. bone formation group at infection status) 
(N = 60).
 3. DEGs that were previously reported to be associated with PD in GWAS (N = 15).
 4. DEGs that located to the novel QTLs Perio3 and Perio4 (N = 6).
Human gene homology mapping and annotation. Identified candidate genes in mice were mapped 
to human genes by using the Genehopper database31. Genehopper contains 27,443 orthologous gene mappings 
between mouse and human (Ensembl)32. All regions of the human orthologous genes + /− 200 kb were annotated 
Cases-Ctrls sample n of CC_RILs (names) phenotype n_cases n_ctrls total
#1 2 (TAU-IL188, TAU-IL111) resistant 4 (2 per line) 4 (2 per line) 8
#2 2 (TAU-IL785, TAU-IL551) susceptible 4 (2 per line) 4 (2 per line) 8
#3 2 (TAU-IL2124, TAU-IL2126) bone formation 4 (2 per line) 4 (2 per line) 8
Total 6 lines 12 12 24
Table 3. Number and characteristics of RILs used for differential expression analysis. Ctrl; control, n; number, 
RILs; recombinant inbred lines.
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with GWAS associations with P < 10−5 from the NHGRI-EBI GWAS Catalog33,34. Currently, the GWAS Catalog 
contains 150 associations (P < 5 ×10−6) with a PD phenotype (Appendix table 5). Moreover, the human ortho-
logues were annotated for expression quantitative trait loci (eQTLs) of the public domain by using Qtlizer (www.
genehopper.de/qtlizer), an annotation method of the Genehopper web application, which is integrating data from 
multiple eQTL databases.
Participating human studies. The meta-analysis samples consisted of case-control GWAS of German and 
Dutch AgP9 and of European American2 and German CP4 patients. The German AgP sample (AgP-Ger) included 
680 cases and 3,973 controls. Cases were recruited across Germany by the biobank Popgen35, University-Hospital 
Schleswig-Holstein, Germany. Controls originated from North- and West-Germany and were recruited from 
the Competence Network “FoCus - Food Chain Plus”36, the Dortmunder Gesundheitsstudie – DOGS37 and the 
Heinz Nixdorf Recall Studies 1–338. The Dutch AgP sample (AgP-NL) consisted of 171 cases and 2,607 controls. 
The Dutch cases were recruited from the ACTA (Academisch Centrum Tandheelkunde Amsterdam) and the 
Dutch controls were recruited from Rotterdam and Wageningen by the B-Proof Study39. Inclusion criteria for 
AgP were ≥ 2 affected teeth with ≥ 30% bone loss in patients <36 years of age; disease phenotype was diag-
nosed by full mouth dental radiographs. Genotype imputation was performed using 1000 Genomes Phase 3 
reference panel40. A detailed quality control and imputation workflow is described in9. The European-American 
CP (CP-EA) sample included 958 severe (sev) CP cases, 2,293 moderate (mod) CP cases and 1,909 controls 
from the Atherosclerosis Risk in Communities (ARIC) Study and were described before41. In brief, the patients 
were classified by the Centers for Disease Control/American Academy of Periodontology (CDC/AAP) consen-
sus three-level classification system42. The CDC/AAP taxonomy uses clinical attachment loss (CAL) and PD 
criteria to define three CP categories as healthy-mild, moderate, and severe CP cases, the first being the control. 
Genotyping was carried out using the Affymetrix Genome-Wide Human SNP Array 6.0 and the subsequent gen-
otype imputation was performed on the HapMap Phase II reference with individuals of Northern and Western 
European (CEU) ancestry. The German CP (CP-Ger) sample, which consisted of 993 cases and 1,419 controls 
from a meta-analysis of SHIP and SHIP-TREND cohorts43–45 was used for validation of the results of the explor-
ative meta-analysis and also included in the pooled analysis that comprised all samples. In brief, subjects within 
the first and the third tertile of proportion of proximal sites with attachment loss (AL) ≥ 4 mm were contrasted 
after stratification by sex and 10-year age groups. Age-specific tertiles were defined to include severely diseased 
cases within each age stratum. Thus, also young and severely diseased subjects were captured and included in 
the third tertile. Otherwise, those in the third tertile would have been the older ones and those in the first tertile 
would have included the younger ones only. Individuals aged> 60 years were excluded. The identification of 
these subjects is important as we assume that genetic predispositions might manifest especially in younger age, 
while in older subjects these effects are overlaid with environmental risk factor associated disease progression. 
This case-control sample was previously described in detail4. Cases and controls were genotyped either with the 
Affymetrix Genome-Wide Human SNP Array 6.0 or the Illumina Human Omni 2.5 array and imputed on the 
1000 Genomes Phase 1 reference.
Filtering. In the post imputation QC processing, variants were excluded, which passed the following cut-off 
criteria: AgP: Hardy-Weinberg-Equilibrium P-value (PHWE) < 10−4, imputation quality (INFO) of <0.89; CP 
(Germany): PHWE ≤ 0.001, imputation quality (r2HAT) ≤ 0.34; CP (European-US): PHWE < 10−5 (ARIC) and 
PHWE < 10−6 (Health ABC), imputation quality <0.82. Moreover, we filtered out variants with a minor allele fre-
quency (MAF) < 0.05 because our study lacked statistical power to analyze rare variants. The variant sets did not 
completely overlap between the different genotype data sets that was mainly due to the different human genome 
references that were used to impute the different data sets. Only variants with genotype data available in each 
study were analyzed in the meta-analysis.
Meta-analysis and mapping to DEGs. We meta-analysed the genome-wide association scans of 
AgP-Ger, AgP-NL, CP-EA-sev, CP-EA-mod and CP-Ger based on the additive model using logistic regression. 
By default, we applied a fixed effects model. However, for variants with a high degree of heterogeneity, i.e. a 
P-value of Cochran’s Q P(Q) < 0.05 and a heterogeneity index I2 > 0.5, we applied a random effects model instead. 
Subsequently, we extracted all associations in the range of the candidate genes + /− 200 kilobases and loci with 
an association of Pmeta < 10−3 were selected.
Data availability
Genotype data for aggressive periodontitis samples and the chronic periodontitis sample with German descent 
are available upon request from the biobanks PopGen (https://www.epidemiologie.uni-kiel.de/biobanking) and 
SHIP (https://www.fvcm.med.uni-greifswald.de/index.html), respectively. Summary statistics for CP-EU can also 
be downloaded (see2).
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